McKesson (NYSE:MCK) Stock Acquired Rep. Jonathan L. Jackson

Representative Jonathan L. Jackson (D-Illinois) recently bought shares of McKesson Co. NYSE: MCK. In a filing disclosed on April 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in McKesson stock on March 4th. The trade occurred in the Representative's "MORGAN STANLEY IRA" account.

Representative Jonathan L. Jackson also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of Salesforce NYSE: CRM on 3/11/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 3/4/2025.

McKesson Stock Down 0.0 %

MCK traded down $0.28 during trading on Monday, reaching $689.08. 346,509 shares of the company's stock were exchanged, compared to its average volume of 878,982. The company has a market capitalization of $86.36 billion, a P/E ratio of 31.55, a PEG ratio of 1.29 and a beta of 0.49. The business has a 50 day moving average price of $642.70 and a 200 day moving average price of $593.86. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $728.32.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. As a group, research analysts forecast that McKesson Co. will post 32.77 EPS for the current year.

Remove Ads

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were given a $0.71 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.41%. McKesson's dividend payout ratio is currently 13.00%.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 188 shares of McKesson stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the transaction, the executive vice president now directly owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the transaction, the chief executive officer now owns 60,664 shares of the company's stock, valued at $36,276,465.36. This represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,110 shares of company stock valued at $10,855,706 in the last 90 days. 0.11% of the stock is owned by company insiders.

Hedge Funds Weigh In On McKesson

Hedge funds have recently added to or reduced their stakes in the company. Capital A Wealth Management LLC bought a new position in shares of McKesson in the 4th quarter valued at about $26,000. Millstone Evans Group LLC acquired a new position in McKesson in the fourth quarter valued at approximately $28,000. Synergy Asset Management LLC bought a new position in McKesson in the fourth quarter valued at approximately $32,000. Crews Bank & Trust acquired a new stake in McKesson during the 4th quarter worth $33,000. Finally, Atala Financial Inc bought a new stake in shares of McKesson during the 4th quarter valued at $34,000. Institutional investors own 85.07% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on MCK shares. Wells Fargo & Company increased their target price on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a report on Friday, March 14th. Citigroup cut their price objective on McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a report on Friday, January 10th. StockNews.com downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Mizuho increased their target price on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research report on Thursday, April 3rd. Finally, Morgan Stanley boosted their price target on shares of McKesson from $642.00 to $745.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Three analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, McKesson has a consensus rating of "Moderate Buy" and a consensus target price of $668.50.

About Representative Jackson

Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois' 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois' 1st Congressional District. He declared candidacy for the 2026 election. Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson's career experience includes working as an investment analyst and an entrepreneur.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.